CUSIP 74065P101COMPRLDQ4 2025
27 filings · latest Feb 13, 2026
Largest reported positions · latest quarter
| # | Fund | Shares | Value |
|---|---|---|---|
| 1 | Orbimed Advisors LLC | 10.91M | $31.64M |
| 2 | Baker Bros. Advisors LP | 10.12M | $29.36M |
| 3 | Vanguard Group Inc | 1.41M | $4.10M |
| 4 | Kynam Capital Management, LP | 788.9K | $2.29M |
| 5 | Two Sigma Investments, LP | 788.7K | $2.29M |
| 6 | Morgan Stanley | 334.9K | $971.3K |
| 7 | Marshall Wace, LLP | 273.9K | $794.3K |
| 8 | Geode Capital Management, LLC | 272.9K | $791.5K |
| 9 |
| 4 | May 15, 2025 | Vaddi Krishna | 13G/A | 13.8% | 6.40M | SEC |
| 5 | Feb 14, 2025 | Vaddi Krishna | 13G/A | 11.0% | 5.49M | SEC |
| 6 | Feb 13, 2025 | Deerfield Mgmt, L.P. | 13G/A | — | — | SEC |
| 7 | Feb 13, 2024 | Ubs Asset Management Americas Inc | 13G/A | — | — | SEC |
| 8 | Feb 12, 2024 | Flynn James E | 13G/A | 9.8% | 4.13M | SEC |
| 9 | Feb 12, 2024 | Vaddi Krishna | 13G/A | 11.1% | 4.91M | SEC |
| 10 | Jan 10, 2024 | Fmr LLC | 13G/A | 0.6% | — | SEC |
See the full Schedule 13D/13G history for Prelude Therapeutics Inc.
Unlock full history| Renaissance Technologies LLC |
| 271.3K |
| $786.8K |
| 10 | Blackrock, Inc. | 266.3K | $772.2K |